SBRT Combined With PD-1 Antibody and Chemotherapy in Oligometastatic Nasopharyngeal Carcinoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
SBRT Combined With PD-1 Antibody and Chemotherapy in Oligometastatic Nasopharyngeal Carcinoma	Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, carcinoma, epithelial neoplasm, nasopharyngeal carcinoma, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, otorhinolaryngologic disease	Active, not recruiting	Phase 2	2026-05-07		NCT05524168

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Chongqing University Cancer Hospital	41
First People's Hospital of Foshan	44
Jiangxi Provincial Cancer Hospital	33
Shenzhen People's Hospital	35
Sun Yat-sen University	606
The First Affiliated Hospital of Xiamen University	107

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Sun Yat-sen University Cancer Center	Guangzhou	China	315